{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:11:10Z","timestamp":1771654270263,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s11102-006-9990-9","type":"journal-article","created":{"date-parts":[[2006,8,30]],"date-time":"2006-08-30T13:02:47Z","timestamp":1156942967000},"page":"127-135","source":"Crossref","is-referenced-by-count":13,"title":["Two years of growth hormone replacement therapy in a group of patients with Sheehan\u2019s syndrome"],"prefix":"10.1007","volume":"9","author":[{"given":"D\u00e9bora Vieira","family":"Soares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Diniz Carneiro","family":"Spina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosane Resende","family":"de Lima Oliveira Brasil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila Marise","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Salles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cla\u00fadia Medina","family":"Coeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1via L\u00facia","family":"Concei\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Vaisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,8,30]]},"reference":[{"key":"9990_CR1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","volume":"336","author":"T Ros\u00e9n","year":"1990","unstructured":"Ros\u00e9n T, Bengtsson B-\u00c5 (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285\u2013288","journal-title":"Lancet"},{"key":"9990_CR2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","volume":"46","author":"B B\u00fclow","year":"1997","unstructured":"B\u00fclow B, Hagmar L, Mikoczy Z, Nordstrom CH, Erfurth EM (1997) Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol (Oxf) 46:75\u201381","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"suppl","key":"9990_CR3","first-page":"OC9","volume":"152","author":"AS Bates","year":"1997","unstructured":"Bates AS, Bullivant B, Clayton RN, Sheppard MC, Stwert PM (1997) Increased mortality in hypopituitarism is not due to an increase in vascular mortality. J Endocrinol 152(suppl):OC9","journal-title":"J Endocrinol"},{"key":"9990_CR4","first-page":"1169","volume":"81","author":"AS Bates","year":"1996","unstructured":"Bates AS, Van\u2019t Hoff W, Jones PJ, Clayton RN (1996) The effect of hypopytuitarism of life expectancy. J Clin Endocrinol Metab 81:1169\u20131172","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","volume":"357","author":"JW Tomlinson","year":"2001","unstructured":"Tomlinson JW, Holden N, Hills RK et\u00a0al (2001) Association between premature mortality and hypopituitarism. Lancet 357:425\u2013431","journal-title":"Lancet"},{"key":"9990_CR6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/acta.0.1290195","volume":"29","author":"T Ros\u00e9n","year":"1993","unstructured":"Ros\u00e9n T, Ed\u00e9n S, Larson G, Wilhelmsen L, Bengtsson B-\u00c5 (1993) Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta endocrinol 29:195\u2013200","journal-title":"Acta endocrinol"},{"key":"9990_CR7","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/0140-6736(92)92892-J","volume":"340","author":"V Markussis","year":"1992","unstructured":"Markussis V, Beshyam SA, Fisher C, Sharp P, Nicolaides NA, Johnston DG (1992) Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 340:1188\u20131192","journal-title":"Lancet"},{"key":"9990_CR8","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/ajcn\/55.5.918","volume":"55","author":"A Binnerts","year":"1992","unstructured":"Binnerts A, Deurenberg P, Swart GR, Wilson JHP, Lamberts SWJ (1992) Body composition in growth hormone-deficient adults. Am J Clin Nutr 55:918\u2013923","journal-title":"Am J Clin Nutr"},{"key":"9990_CR9","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/0026-0495(95)90004-7","volume":"44","author":"J-O Johanson","year":"1995","unstructured":"Johanson J-O, Fowelin J, Landin K, Larger I, Bengtsson B-\u00c5 (1995) Growth hormone deficient adults are insulin-resistant. Metabolism 44:1126\u20131129","journal-title":"Metabolism"},{"key":"9990_CR10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.14.3.434","volume":"14","author":"J-O Johansson","year":"1994","unstructured":"Johansson J-O, Landin K, Tengborn L, Ros\u00e9n T, Bengtsson B-\u00c5 (1994) High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscler Thromb 14:434\u2013437","journal-title":"Arterioscler Thromb"},{"key":"9990_CR11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/jappl.1991.70.2.695","volume":"70","author":"RC Cuneo","year":"1991","unstructured":"Cuneo RC, Salomon F, Wiles CM, Hesp R, S\u00f6nksen PH (1991) Growth hormone treatment in growth hormone deficient adults. II Effects on exercise performance. J Appl Physiol 70:695\u2013700","journal-title":"J Appl Physiol"},{"key":"9990_CR12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/path.1700450118","volume":"45","author":"HL Sheehan","year":"1973","unstructured":"Sheehan HL (1973) Postpartum necrosis of anterior pituitary. J Pathol Bact 45:189\u2013214","journal-title":"J Pathol Bact"},{"key":"9990_CR13","first-page":"93","volume-title":"Challenges in Growth Hormone Therapy","author":"SA Beshyah","year":"1999","unstructured":"Beshyah SA (1999) Is cardiovascular mortality increased in hypopituitary adults? In: Monson JP (ed) Challenges in growth hormone therapy. Philadelphia, Blackwell Science, pp 93\u2013105"},{"key":"9990_CR14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","volume":"83","author":"PV Carrol","year":"1998","unstructured":"Carrol PV, Christ ER, Bengtsson B-\u00c5 et\u00a0al (1998) Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83:382\u2013385","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR15","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","volume":"321","author":"F Salomon","year":"1989","unstructured":"Salomon F, Cuneo RC, Hesp R, S\u00f6nksen PH (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797\u20131803","journal-title":"N Engl J Med"},{"key":"9990_CR16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","volume":"1","author":"JOL J\u00f8rgensen","year":"1989","unstructured":"J\u00f8rgensen JOL, Pedersen SA, Thuesen L et\u00a0al (1989) Beneficial effect of growth hormone treatment in GH-deficient adults. Lancet 1:1221\u20131225","journal-title":"Lancet"},{"key":"9990_CR17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/edrv-8-2-115","volume":"8","author":"MB Davidson","year":"1987","unstructured":"Davidson MB (1987) Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 8:115\u2013131","journal-title":"Endocr Rev"},{"key":"9990_CR18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1210\/jcem-55-5-973","volume":"55","author":"PR Bratusch-Marrain","year":"1982","unstructured":"Bratusch-Marrain PR, Smith D, DeFronzo RA (1982) The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 55:973\u2013982","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1530\/eje.1.01881","volume":"152","author":"F Kelestimur","year":"2005","unstructured":"Kelestimur F, Jonsson P, Molvalidar S et\u00a0al (2005) Sheehan\u2019s syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS\u2014Pfizer International Metabolic Database. Eur J Endocrinol 152:581\u2013587","journal-title":"Eur J Endocrinol"},{"key":"9990_CR20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ghir.2005.03.005","volume":"15","author":"F Tanriverdi","year":"2005","unstructured":"Tanriverdi F, Unluhizarci K, Kula M et\u00a0al (2005) Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan\u2019s syndrome. Growth Horm IGF Res 15:231\u2013237","journal-title":"Growth Horm IGF Res"},{"key":"9990_CR21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"Mathews","year":"1985","unstructured":"Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis Model Assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"9990_CR22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, Defronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance test: comparison with the euglycemic clamp. Diabetes Care 22:1462\u20131470","journal-title":"Diabetes Care"},{"key":"9990_CR23","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","volume":"20","author":"The Expert Committee on the diagnosis and classification of diabetes mellitus","year":"1997","unstructured":"The Expert Committee on the diagnosis and classification of diabetes mellitus (1997) Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183\u20131197","journal-title":"Diabetes Care"},{"key":"9990_CR24","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.CIR.74.6.1399","volume":"74","author":"P Pignoli","year":"1986","unstructured":"Pignoli P, Tremoli H, Poli A, Oreste P, Paoletti R (1986) Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74:1399\u20131406","journal-title":"Circulation"},{"key":"9990_CR25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.metabol.2004.09.011","volume":"54","author":"DV Soares","year":"2005","unstructured":"Soares DV, Spina LDC, Brasil RRLO et\u00a0al (2005) Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement. Metabolism 54:321\u2013329","journal-title":"Metabolism"},{"key":"9990_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-005-4918-2","volume":"7","author":"LDC Spina","year":"2005","unstructured":"Spina LDC, Soares DV, Brasil RRLO et\u00a0al (2005) Glucose metabolism and visceral fat in GH deficient adults: two years of GH-replacement. Pituitary 7:1\u20137","journal-title":"Pituitary"},{"key":"9990_CR27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.ATV.21.2.262","volume":"21","author":"P Angerer","year":"2001","unstructured":"Angerer P, St\u00f6rk S, Kothny W, Schimitt P, von Schacky C (2001) Effects of oral postmenopausal hormone replacement on progression of atherosclerosis. Arterioscl Thormb Vasc Biol 21:262\u2013268","journal-title":"Arterioscl Thormb Vasc Biol"},{"key":"9990_CR28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.CIR.88.1.20","volume":"88","author":"DH Blankenhorn","year":"1993","unstructured":"Blankenhorn DH, Selzer RH, Crawford DW et\u00a0al (1993) Beneficial effects of cholestipol-niacin therapy on the common carotid artery. Circulation 88:20\u201328","journal-title":"Circulation"},{"key":"9990_CR29","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/0003-4819-124-6-199603150-00002","volume":"124","author":"HN Hodis","year":"1996","unstructured":"Hodis HN, Mack WJ, LaBree L et\u00a0al (1996) Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med 124:548\u2013556","journal-title":"Ann Intern Med"},{"key":"9990_CR30","first-page":"453","volume":"84","author":"M Pfeifer","year":"1999","unstructured":"Pfeifer M, Verhovec R, \u017di\u017eek B, Pre\u017eelj J, Poredo\u0161 P, Clayton RN (1999) Growth (GH) hormone treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab 84:453\u2013457","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1530\/eje.0.1480333","volume":"148","author":"M Murata","year":"2003","unstructured":"Murata M, Kaji H, Mizuno I et\u00a0al (2003) A study of carotid intima-media thickness in GH-deficient Japanese adults during onset among adults and children. Eur J Endocrinol 148:333\u2013338","journal-title":"Eur J Endocrinol"},{"key":"9990_CR32","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1210\/jcem.86.3.7268","volume":"86","author":"R Lanes","year":"2001","unstructured":"Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O, Revel-Chion R (2001) Cardiac mass and function, carotid artery intima-media thickness and lipoprotein levels in growth hormone-deficient adolescents. J Clin Endocrinol Metab 86:1061\u20131065","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR33","first-page":"574","volume":"85","author":"B B\u00fclow","year":"2000","unstructured":"B\u00fclow B, Hagmar L, Eskilsson J, Erfurth EM (2000) Hypopituitary females have a high incidence of cardiovascular morbidity and increased prevalence of cardiovascular risk factors. J Clin Endocrinol Metab 85:574\u2013584","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR34","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1210\/jcem.86.9.7813","volume":"86","author":"TA Elhadd","year":"2001","unstructured":"Elhadd TA, Abdu TA, Oxtoby J et\u00a0al (2001) Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency. J Clin Endocrinol Metab 86:4223\u20134232","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR35","first-page":"1329","volume":"84","author":"F Borson-Chazot","year":"1999","unstructured":"Borson-Chazot F, Serusclat A, Kalfallah Y et\u00a0al (1999) Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency. J Clin Endocrinol Metab 84:1329\u20131333","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR36","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.84.8.5916","volume":"84","author":"J Gibney","year":"1999","unstructured":"Gibney J, Wallace JD, Spinks T et\u00a0al (1999) The effects of 10 years of recombinant human growth hormone (GH) in adults GH-deficient patients. J Clin Endocrinol Metab 84:2596\u20132602","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR37","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1210\/jcem.87.5.8482","volume":"87","author":"J Svensson","year":"2002","unstructured":"Svensson J, Fowelin J, Landin K, Bengtsson B-\u00c5, Johansson J-O (2002) Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. J Clin Endocrinol Metab 87:2121\u20132127","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR38","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0038-1650594","volume":"76","author":"J-O Johansson","year":"1996","unstructured":"Johansson J-O, Landin K, Johannsson G, Tengborn L, Bengtsson B-\u00c5 (1996) Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Thromb and Haemost 76:422\u2013428","journal-title":"Thromb and Haemost"},{"key":"9990_CR39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1054\/ghir.1999.0102","volume":"9","author":"DN O\u2019Neal","year":"1999","unstructured":"O\u2019Neal DN, Hew FL, Best JD, Aford F (1999) The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo[a] in hypopituitary adults previously treated with conventional replacement therapy. Growth Horm IGF Res 9:165\u2013173","journal-title":"Growth Horm IGF Res"},{"key":"9990_CR40","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1210\/jcem.86.10.7896","volume":"86","author":"J Koranyi","year":"1999","unstructured":"Koranyi J, Svensson J, G\u00f6therstr\u00f6m G, Sunnerhagen KS, Bengtsson B-\u00c5, Johannsson G (1999) Baseline Characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study. J Clin Endocrinol Metab 86:4693\u20134699","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-2265.1998.00460.x","volume":"48","author":"K A S Al-Shoumer","year":"1998","unstructured":"Al-Shoumer KAS, Gray R, Anyaoku V et\u00a0al (1998) Effects of four years\u2019 treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clin Endocrinol 48:795\u2013802","journal-title":"Clin Endocrinol"},{"key":"9990_CR42","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1210\/jcem.86.10.7887","volume":"86","author":"G G\u00f6therstr\u00f6m","year":"2001","unstructured":"G\u00f6therstr\u00f6m G, Svensson J, Koranyi J et\u00a0al (2001) A prospective study of 5 years of GH replacement therapy in GH-deficient adults: Sustained effects on body composition, bone mass and metabolic indices. J Clin Endocrinol Metab 86:4657\u20134665","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1530\/eje.0.1370459","volume":"137","author":"W Nolte","year":"1997","unstructured":"Nolte W, R\u00e4disch C, Armstrong VW, H\u00fcfner M, von zur M\u00fchlen A (1997) The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial. Eur J Endocrinol 137:459\u2013466","journal-title":"Eur J Endocrinol"},{"key":"9990_CR44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2265.2002.01508.x","volume":"56","author":"RD Murray","year":"2002","unstructured":"Murray RD, Wieringa GE, Lissett CA, Darzy KH, Smethurst LE, Shalet MS (2002) Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome. Clin Endocrinol 56:525\u2013532","journal-title":"Clin Endocrinol"},{"key":"9990_CR45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.0.1340061","volume":"134","author":"P Garry","year":"1996","unstructured":"Garry P, Collins P, Devlin JD (1996) An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adults acquired growth hormone deficiency. Eur J Endocrinol 134:61\u201366","journal-title":"Eur J Endocrinol"},{"key":"9990_CR46","first-page":"3762","volume":"85","author":"A Chirsoulidou","year":"2000","unstructured":"Chirsoulidou A, Beshyah SA, Rutherford O et\u00a0al (2000) Effects of 7 years of growth hormone replacement therapy in hypopituitary adults. J Clin Endocrinol Metab 85:3762\u20133769","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0021-9150(97)00110-X","volume":"133","author":"JM Webster","year":"1997","unstructured":"Webster JM, Stewart M, Al-Maskari M et\u00a0al (1997) The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein(a) in growth hormone deficient adults. Atherosclerosis 133:115\u2013121","journal-title":"Atherosclerosis"},{"key":"9990_CR48","first-page":"356","volume":"80","author":"SA Beshyah","year":"1995","unstructured":"Beshyah SA, Henderson A, Niththyananthan R et\u00a0al (1995) The effects of short and long term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. J Clin Endocrinol Metab 80:356\u2013363","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl A","key":"9990_CR49","first-page":"31","volume":"1","author":"E Modigliani","year":"1994","unstructured":"Modigliani E, Kerchouni R, Uzzan B, Valensi P, Chanson P, Caron J (1994) Modification of blood lipids and lipoproteins after human growth hormone treatment in adults with growth hormone deficiency: a preliminary report. Endocrinol and Metab 1(Suppl A):31\u201335","journal-title":"Endocrinology and Metabolism"},{"key":"9990_CR50","first-page":"153","volume":"80","author":"JU Weaver","year":"1995","unstructured":"Weaver JU, Monson JP, Noonan K et\u00a0al (1995) The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab 80:153\u2013159","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR51","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1161\/01.ATV.15.12.2142","volume":"15","author":"G Johannsson","year":"1995","unstructured":"Johannsson G, Oscarsson J, Ros\u00e9n T et\u00a0al (1995) Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and apo(a) and apoE phenotypes. Arterioscler Thromb Vasc Biol 15:2142\u20132150","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9990_CR52","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, \u00d6unpuu S et\u00a0al (2004) Effect of potentially modifiable risk factors associated with myocardial infartation in 52 countries (the INTERHEART study): case control study. Lancet 364:937\u2013952","journal-title":"Lancet"},{"key":"9990_CR53","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1515\/CCLM.2004.254","volume":"42","author":"G Walldius","year":"2004","unstructured":"Walldius G, Jungner I, Aastveit AH et\u00a0al (2004) The apoB\/apoA-I ration is better than the cholesterol rations to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 42:1355\u20131363","journal-title":"Clin Chem Lab Med"},{"key":"9990_CR54","first-page":"117","volume-title":"Growth hormone deficiency in adults: 10 years of KIMS","author":"H Mersebach","year":"2004","unstructured":"Mersebach H, Rasmussen AK, Feldt-Rasmussen U (2004) Body composition and effects of growth hormone. In: Abs R Rasmussen F (eds). Growth hormone deficiency in adults: 10 years of KIMS. Oxford, UK. Oxford Phama GenesisTM Ltd; pp 117\u2013126"},{"key":"9990_CR55","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1210\/jcem.85.11.6930","volume":"85","author":"AM Rosenfalck","year":"2000","unstructured":"Rosenfalck AM, Maghsoudi S, Fisker S et\u00a0al (2000) The effect of 30 months of low dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and c-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. J Clin Endocrinol Metab 85:4173\u20134181","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ghir.2003.08.002","volume":"14","author":"LDC Spina","year":"2004","unstructured":"Spina LDC, Soares DV, Brasil RRLO et\u00a0al (2004) Glucose metabolism and visceral fat in GH defiancient adults: 1 year of GH replacement. Growth Horm IGF Res 14:45\u201351","journal-title":"Growth Horm IGF Res"},{"key":"9990_CR57","first-page":"555","volume":"81","author":"FL Hew","year":"1996","unstructured":"Hew FL, Koschmann M, Chirstopher M et\u00a0al (1996) Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. J Clin Endocrinol Metab 81:555\u2013564","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2265.1998.00502.x","volume":"49","author":"S Seminara","year":"1998","unstructured":"Seminara S, Merello G, Masi S et\u00a0al (1998) Effect of long-term growth hormone treatment on carbohydrate metabolism in children with growth hormone deficiency. Clinical Endocrinol (Oxf) 49:125\u2013130","journal-title":"Clinical Endocrinol (Oxf)"},{"key":"9990_CR59","first-page":"4104","volume":"85","author":"R Fernholm","year":"2000","unstructured":"Fernholm R, Bramnert M, Hagg E et\u00a0al (2000) Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. J Clin Endocrinol Metab 85:4104\u20134112","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR60","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(99)04055-6","volume":"355","author":"WS Cutfield","year":"2000","unstructured":"Cutfield WS, Wilton P, Bennmark H et\u00a0al (2000) Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth hormone treatment. Lancet 355:610\u2013613","journal-title":"Lancet"},{"key":"9990_CR61","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1530\/eje.0.1350559","volume":"135","author":"KAS Al Shoumer","year":"1996","unstructured":"Al Shoumer KAS, Page B, Thomas E, Murphy M, Beshyah SA, Johnston DG (1996) Effects of four years\u2019 treatment with biosynthetic human growth hormone (GH) on body composition in GH-deficient hypopituitary adults. Eur J Endocrinol 135:559\u2013567","journal-title":"Eur J Endocrinol"},{"key":"9990_CR62","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0026-0495(93)90197-V","volume":"42","author":"J Fowelin","year":"1993","unstructured":"Fowelin J, Attvall S, Lager I, Bengtsson B-A (1993) Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 42:1443\u20131447","journal-title":"Metabolism"},{"key":"9990_CR63","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1530\/eje.0.1300224","volume":"130","author":"JO Jorgensen","year":"1994","unstructured":"Jorgensen JO, Thuesen L, Muller J, Ovesen P, Skakkebaek NE, Christiansen JS (1994) Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance. Eur J Endocrinol 130:224\u2013228","journal-title":"Eur J Endocrinol"},{"key":"9990_CR64","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(05)73137-8","volume":"355","author":"JP Monson","year":"2000","unstructured":"Monson JP, Bengtsson BA, Abs R, Feldt-Rasmussen U, Wuster C (2000) Can growth hormone therapy cause diabetes? KIMS Strategic Committee. Lancet 355:1728\u20131729","journal-title":"Lancet"},{"key":"9990_CR65","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1210\/jcem.87.5.8460","volume":"87","author":"K Yuen","year":"2002","unstructured":"Yuen K, Ong K, Husbands S et\u00a0al (2002) The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults. J Clin Endocrinol Metab 87:1989\u20131995","journal-title":"J Clin Endocrinol Metab"},{"key":"9990_CR66","first-page":"260","volume":"48","author":"D Micic","year":"2002","unstructured":"Micic D, Cvijovic G, Doknic M, Kendereski A, Popovic V (2002) Effect of 12 months of recombinant human growth hormone replacement therapy on insulin sensitivity in GH-deficient adults as determined by different methods. J Post Grad Med 48:260\u2013265","journal-title":"J Post Grad Med"},{"key":"9990_CR67","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ghir.2004.06.004","volume":"14","author":"DV Soares","year":"2004","unstructured":"Soares DV, Concei\u00e7\u00e3o FL, Brasil RRLO et\u00a0al (2004) Insulin-like growth factor I levels during growth hormone (GH) replacement in GH-deficient adults: a gender difference. Growth Horm IGF Res 14:436\u2013441","journal-title":"Growth Horm IGF Res"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-006-9990-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-006-9990-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-006-9990-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T03:02:29Z","timestamp":1587178949000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-006-9990-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["9990"],"URL":"https:\/\/doi.org\/10.1007\/s11102-006-9990-9","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}